Fylo›ARCADIA›Graph
Hubs
Association·arcadia

48/80 induces β-hexosaminidase release in mast cell models

Claim that only compound 48/80, among tested mast cell activators, induces β-hexosaminidase release (degranulation) in both HMC1.2 and RBL-2H3 cell lines.

Confidence
100%
active

Evidence Quote

“Only 48/80 induced β-hexosaminidase release from either HMC1.2 or RBL-2H3”

Relationship

Compound 48/80 treatment increases β-hexosaminidase release

Arguments

Compound 48/80 treatmentsubject
β-hexosaminidase releaseobject

Connections (4)

Assay inactivation due to toxicity and lack of suitable activatorInferenceChain
48/80 induces β-hexosaminidase release in mast cell modelsAssociation
Limits of using compound 48/80 and standard mast cell lines in tick saliva researchInferenceChain
Divergent activator mechanisms via MRGPRX2 pathwayInferenceChain

Evidence

“Reference to Karagiannis SN et al. (2013). Immunoglobulin E and Allergy: Antibodies in Immune Inflammation and Treatment.”

Karagiannis SN et al. (2013). Immunoglobulin E and Allergy: Antibodies in Immune Inflammation and Treatment doi:10.1128/microbiolspec.aid-0006-2012 ↗

“Reference to Yang T-LB, Kim BS. (2019). Pruritus in allergy and immunology.”

Yang T-LB & Kim BS. (2019). Pruritus in allergy and immunology doi:10.1016/j.jaci.2019.06.016 ↗